Indoco Remedies receives USFDA’s approval for Canagliflozin Tablets

06 Dec 2023 Evaluate

Indoco Remedies has received tentative approval from the US Food and Drug Administration (USFDA) for Abbreviated New Drug Application (ANDA) for Canagliflozin Tablets 100 mg and 300 mg, a generic equivalent of the Reference Listed Drug, Invokana Tablets 100 mg and 300 mg, of Janssen Pharmaceuticals, Inc. This product will be manufactured by Indoco Remedies, at their manufacturing facility located at Goa (Plant -I) in India. Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.


Indoco Remedies Share Price

316.30 16.45 (5.49%)
22-Nov-2024 12:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.05
Dr. Reddys Lab 1211.45
Cipla 1488.25
Lupin 2059.45
Zydus Lifesciences 946.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.